| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | - | SEH1L STXBP5L DTL BIRC6 DDB1 DCAF5 HIRA MET SEMA6D POC1B WDR1 GNB3 PLXNA1 | 1.51e-05 | 333 | 174 | 13 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | SEH1L STXBP5L DTL BIRC6 DDB1 DCAF5 HIRA MET SEMA6D POC1B WDR1 GNB3 PLXNA1 | 1.61e-05 | 335 | 174 | 13 | IPR015943 |
| Domain | HARE-HTH | 2.57e-04 | 3 | 174 | 2 | PF05066 | |
| Domain | ASXH | 2.57e-04 | 3 | 174 | 2 | PF13919 | |
| Domain | PHD_3 | 2.57e-04 | 3 | 174 | 2 | PF13922 | |
| Domain | ASX-like_PHD | 2.57e-04 | 3 | 174 | 2 | IPR026905 | |
| Domain | ASXH | 2.57e-04 | 3 | 174 | 2 | IPR028020 | |
| Domain | ASX/ASX-like | 2.57e-04 | 3 | 174 | 2 | IPR024811 | |
| Domain | HB1/Asxl_HTH | 2.57e-04 | 3 | 174 | 2 | IPR007759 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.04e-04 | 35 | 174 | 4 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 4.19e-04 | 38 | 174 | 4 | PS00690 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SEH1L FLNA FLNB ILF3 DSTN GATAD2A EP400 MYO5A DHX37 SRP54 SLU7 U2AF2 RPL14 BIRC6 DDB1 GFPT1 HIRA EEF2 ADSL AHNAK PIP4K2A A2ML1 SFXN3 MKI67 PYCR1 WDR1 KIF18B ALDH9A1 DHX29 ANKRD52 VARS1 MED12 | 9.80e-13 | 1353 | 183 | 32 | 29467282 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | SEH1L FLNA FLNB SIGMAR1 SPTLC1 GPX7 SIRPB2 RPL14 SIN3A ERGIC2 ZFYVE1 DDB1 DCAF5 GFPT1 ECHDC3 EEF2 FAT1 ADSL MAVS P4HA1 UBAP2L P3H1 MTIF2 ASXL3 AHNAK RAB3GAP2 PIP4K2A SFXN3 PYCR1 PIP4K2B TAP1 VARS1 PLXNA1 | 1.19e-12 | 1451 | 183 | 33 | 30550785 |
| Pubmed | NUSAP1 FLNB EP400 ZFYVE16 ATG2B SRP54 MED13L HIRA FAM111B PHKB ADSL UBAP2L AHNAK PIP4K2A PIP4K2B C3 CHD6 KIF18B LRIF1 MED12 PCNT | 3.65e-11 | 645 | 183 | 21 | 25281560 | |
| Pubmed | TNIK COL5A1 FLNA FLNB VRK2 ZFYVE16 SIGMAR1 DHX37 SPTLC1 SRP54 RPL14 ERGIC2 BIRC6 GFPT1 STAT3 MET EEF2 FAT1 PXDN P4HA1 UBAP2L P3H1 AHNAK MKI67 C3 ALDH9A1 TAP1 | 1.17e-09 | 1297 | 183 | 27 | 33545068 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | SEH1L FLNA FLNB DSTN SIGMAR1 AAMDC SRP54 SIN3A XPNPEP1 DDB1 SLC1A4 GFPT1 GSN EEF2 MAVS P4HA1 UBAP2L EPHA2 AHNAK A2ML1 SFXN3 PYCR1 ALCAM WDR1 DHX29 VARS1 KNL1 | 3.58e-09 | 1367 | 183 | 27 | 32687490 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TNIK FLNA ILF3 EP400 ZFYVE16 ATG2B SRP54 RPL14 SIN3A DDB1 GFPT1 STAT3 ORC2 MAVS UBAP2L AHNAK MKI67 RPRD2 WDR1 DHX29 KNL1 PCNT | 5.15e-09 | 934 | 183 | 22 | 33916271 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | FLNA ILF3 MYO5A DHX37 SRP54 U2AF2 ZFYVE1 GSN HIRA UBAP2L EPHA2 AHNAK PIP4K2A SFXN3 MKI67 KIF18B DHX29 VARS1 ZNF292 | 1.12e-08 | 724 | 183 | 19 | 36232890 |
| Pubmed | TNIK SEH1L VRK2 ILF3 ANK3 MYO5A POLE2 SPTLC1 SRP54 SLU7 RPL14 DDB1 DCAF5 TUBGCP6 MET TIMM21 P4HA1 P3H1 MTIF2 EPHA2 RAB3GAP2 PYCR1 SENP2 ALDH9A1 DHX29 ANKRD52 PCNT | 2.07e-08 | 1487 | 183 | 27 | 33957083 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | FLNA FLNB ILF3 MYO5A ATG2B U2AF2 DDB1 STAT3 GSN EEF2 AHNAK TAP1 | 2.17e-08 | 268 | 183 | 12 | 33024031 |
| Pubmed | TNIK ASXL1 EP400 ZFYVE16 HIPK1 MED13L DCAF5 PXDN SEMA6D UBAP2L RAB3GAP2 SENP2 CHD6 PCNT | 3.93e-08 | 407 | 183 | 14 | 12693553 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | FLNA FLNB ILF3 U2AF2 BIRC6 DDB1 PHKB ADSL UBAP2L C3 WDR1 VARS1 NCKAP1L | 4.10e-08 | 344 | 183 | 13 | 30333137 |
| Pubmed | COL5A1 FLNA FLNB MYO5A DHX37 U2AF2 RPL14 BIRC6 DDB1 GFPT1 TASOR2 UBAP2L AHNAK MKI67 ANKRD52 MED12 PCNT | 7.69e-08 | 653 | 183 | 17 | 22586326 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | FLNA VRK2 ILF3 GATAD2A EP400 DHX37 SPTLC1 U2AF2 RPL14 ERGIC2 STAT3 ORC2 EEF2 TRNT1 P4HA1 UBAP2L AHNAK PIP4K2A MKI67 PYCR1 PIP4K2B CHD6 VARS1 LRIF1 | 1.30e-07 | 1318 | 183 | 24 | 30463901 |
| Pubmed | DENND2A FLNA DPP6 FLNB ILF3 DSTN ANK3 MYO5A NCAM2 RPL14 DDB1 SLC1A4 GSN PHKB EEF2 UBAP2L VCAN SVIL PIP4K2A SFXN3 SCAPER WDR1 GNB3 DHX29 VARS1 | 1.52e-07 | 1431 | 183 | 25 | 37142655 | |
| Pubmed | 1.54e-07 | 46 | 183 | 6 | 33403043 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NUSAP1 FLNA FLNB ILF3 MYO5A DHX37 U2AF2 RPL14 DDB1 GFPT1 GSN FAM111B EEF2 PXDN AHNAK SVIL MKI67 C3 WDR1 VARS1 | 1.62e-07 | 949 | 183 | 20 | 36574265 |
| Pubmed | FLNB ILF3 ANK3 ZFYVE16 ATG2B RPL14 XPNPEP1 DDB1 GFPT1 STAT3 EEF2 UBAP2L EPHA2 AHNAK RAB3GAP2 DHX29 MED12 | 2.41e-07 | 708 | 183 | 17 | 39231216 | |
| Pubmed | NUSAP1 FLNA FLNB ANK3 DTL SRP54 SLU7 FAM171B ZFYVE1 DCAF5 PHKB TRNT1 UBAP2L VCAN SFXN3 ARID5B SPRED1 KIF13A PCDH18 PCNT NCKAP1L | 3.12e-07 | 1084 | 183 | 21 | 11544199 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | COL5A1 DPP6 FLNB ANK3 MYO5A SIGMAR1 STXBP5L SRP54 U2AF2 NCAM2 TFAP4 TASOR2 MSRA PHKB TRNT1 PXDN UBAP2L SFXN3 ARID5B LRP5 RPRD2 CHD6 ALCAM GREB1 PCNT | 3.19e-07 | 1489 | 183 | 25 | 28611215 |
| Pubmed | FLNA FLNB ZFYVE16 ATG2B BIRC6 AHNAK RAB3GAP2 ARID5B CHD6 ANKRD52 MED12 KNL1 PCNT | 3.84e-07 | 418 | 183 | 13 | 34709266 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL5A1 ATR SIGMAR1 SPTLC1 ERGIC2 LRP1B DDB1 MET EEF2 THBS3 FAT1 PXDN ADSL P4HA1 P3H1 EPHA2 SVIL SCAPER LRP5 ALCAM TAP1 PLXNA1 | 4.11e-07 | 1201 | 183 | 22 | 35696571 |
| Pubmed | GATAD2A EP400 SPTLC1 U2AF2 SIN3A DDB1 DCAF5 TUBGCP6 FAT1 RASAL3 TIMM21 P4HA1 MTIF2 PIP4K2A SCAPER PIP4K2B KIF18B ANAPC5 ANKRD52 GARRE1 KNL1 | 5.00e-07 | 1116 | 183 | 21 | 31753913 | |
| Pubmed | FLNA FLNB ILF3 GATAD2A DTL GFPT1 EEF2 MAVS UBAP2L MKI67 RPRD2 KIF13A DHX29 ANKRD52 | 5.14e-07 | 503 | 183 | 14 | 16964243 | |
| Pubmed | NUSAP1 ASXL1 GATAD2A EP400 MYO5A DHX37 SLU7 RPL14 SIN3A DDB1 TFAP4 DCAF5 STAT3 HIRA FAT1 UBAP2L SVIL ARID5B MKI67 RPRD2 CHD6 WDR1 GARRE1 LRIF1 | 5.58e-07 | 1429 | 183 | 24 | 35140242 | |
| Pubmed | NuSAP is essential for chromatin-induced spindle formation during early embryogenesis. | 5.71e-07 | 4 | 183 | 3 | 20807801 | |
| Pubmed | TNIK FLNA FLNB ANK3 MYO5A STXBP5L ATG2B RPL14 FAM171B BIRC6 LRP1B SLC1A4 MET OSBP UBAP2L RAB3GAP2 SFXN3 PIP4K2B ALDH9A1 DHX29 VARS1 | 6.94e-07 | 1139 | 183 | 21 | 36417873 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FLNA FLNB ILF3 DSTN ANK3 MYO5A U2AF2 RPL14 DDB1 GSN PHKB EEF2 P4HA1 UBAP2L AHNAK RAB3GAP2 SVIL PYCR1 WDR1 ALDH9A1 VARS1 | 7.98e-07 | 1149 | 183 | 21 | 35446349 |
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 8.40e-07 | 247 | 183 | 10 | 39238192 | |
| Pubmed | FLNA MYO5A GFPT1 GSN EEF2 AHNAK RAB3GAP2 SVIL SFXN3 WDR1 VARS1 | 9.20e-07 | 312 | 183 | 11 | 37120454 | |
| Pubmed | TNIK NUSAP1 FLNA VRK2 ILF3 GATAD2A EP400 DHX37 SRP54 U2AF2 RPL14 DDB1 GFPT1 STAT3 EEF2 P4HA1 UBAP2L EPHA2 AHNAK SVIL MKI67 PYCR1 VARS1 | 1.00e-06 | 1371 | 183 | 23 | 36244648 | |
| Pubmed | NUSAP1 FLNA FLNB ILF3 DHX37 PCDHAC1 SRP54 U2AF2 RPL14 DDB1 DCAF5 EEF2 UBAP2L SCAPER PYCR1 UNC13C ANAPC5 DHX29 NCKAP1L | 1.02e-06 | 971 | 183 | 19 | 33306668 | |
| Pubmed | FLNA ILF3 MYO5A SLU7 RPL14 ERGIC2 PARP14 BIRC6 SLC1A4 TUBGCP6 ORC2 EEF2 RASAL3 P4HA1 P3H1 AHNAK MKI67 TAP1 MED12 PCNT NCKAP1L | 1.04e-06 | 1168 | 183 | 21 | 19946888 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SEH1L FLNA FLNB ZFYVE16 POLE2 DTL DDB1 GFPT1 GSN ADSL EPHA2 SFXN3 PYCR1 C3 WDR1 ALDH9A1 DHX29 ANKRD52 VARS1 | 1.07e-06 | 974 | 183 | 19 | 28675297 |
| Pubmed | 1.21e-06 | 102 | 183 | 7 | 26584622 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NUSAP1 SEH1L FLNA FLNB VRK2 ILF3 DHX37 U2AF2 RPL14 SIN3A DDB1 RFTN1 EEF2 AHNAK MKI67 PYCR1 KIF18B VARS1 KNL1 | 1.34e-06 | 989 | 183 | 19 | 36424410 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.37e-06 | 202 | 183 | 9 | 33005030 | |
| Pubmed | LRRC8E GATAD2A EP400 SIN3A PARP14 BIRC6 DDB1 TASOR2 ORC2 UBAP2L AHNAK SENP2 CHD6 | 1.39e-06 | 469 | 183 | 13 | 27634302 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NUSAP1 SEH1L VRK2 ILF3 GATAD2A ATR EP400 U2AF2 RPL14 SIN3A DDB1 TFAP4 HIRA ORC2 AHNAK ARID5B MKI67 RPRD2 CHD6 KIF18B ANAPC5 LRIF1 | 1.41e-06 | 1294 | 183 | 22 | 30804502 |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.43e-06 | 203 | 183 | 9 | 22083510 | |
| Pubmed | 1.55e-06 | 152 | 183 | 8 | 16009940 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | LRRC8E FLNA VRK2 VGLL3 SIGMAR1 SPTLC1 RPL14 SIN3A ERGIC2 SLC1A4 STAT3 ORC2 EEF2 TIMM21 AHNAK ARID5B MKI67 ALCAM WDR1 TAP1 MED12 | 1.65e-06 | 1203 | 183 | 21 | 29180619 |
| Pubmed | NUSAP1 SEH1L FLNA ILF3 GATAD2A EP400 SRP54 SLU7 SIN3A MED13L TFAP4 GSN EEF2 RAB3GAP2 MKI67 VARS1 LRIF1 MED12 KNL1 ZNF292 | 1.68e-06 | 1103 | 183 | 20 | 34189442 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | FLNA FLNB EP400 U2AF2 SIN3A XPNPEP1 EEF2 P4HA1 UBAP2L AHNAK VARS1 | 1.68e-06 | 332 | 183 | 11 | 32786267 |
| Pubmed | 1.75e-06 | 268 | 183 | 10 | 33640491 | ||
| Pubmed | TNIK VRK2 EP400 ZFYVE16 DTL BIRC6 DDB1 MAVS P4HA1 RAB3GAP2 PIP4K2B RPRD2 CHD6 ALDH9A1 VARS1 KNL1 | 1.91e-06 | 733 | 183 | 16 | 34672954 | |
| Pubmed | NUSAP1 ILF3 DSTN GATAD2A ATR EP400 SRP54 SIN3A MED13L DDB1 TFAP4 GFPT1 STAT3 EEF2 TRNT1 AHNAK MKI67 WDR1 MED12 | 1.93e-06 | 1014 | 183 | 19 | 32416067 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.94e-06 | 271 | 183 | 10 | 32433965 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | ILF3 EP400 SIN3A PARP14 DDB1 HIRA ORC2 TRNT1 MKI67 GREB1 MED12 | 2.18e-06 | 341 | 183 | 11 | 32971831 |
| Pubmed | FLNA ILF3 DSTN GATAD2A U2AF2 RPL14 SIN3A DDB1 DCAF5 GFPT1 EEF2 P4HA1 UBAP2L MKI67 CHD6 | 2.26e-06 | 655 | 183 | 15 | 35819319 | |
| Pubmed | FLNA FLNB ILF3 GLS2 MYO5A DTL U2AF2 RPL14 TASOR2 RFTN1 EEF2 TRNT1 PXDN TIMM21 AHNAK PIP4K2A PYCR1 PIP4K2B CHD6 ALCAM VARS1 ZNF292 PCNT | 2.34e-06 | 1442 | 183 | 23 | 35575683 | |
| Pubmed | 2.45e-06 | 41 | 183 | 5 | 19805454 | ||
| Pubmed | 2.86e-06 | 116 | 183 | 7 | 30804394 | ||
| Pubmed | NUSAP1 VRK2 ANK3 MYO5A ZFYVE16 FAM171B BIRC6 PHKB RFTN1 P4HA1 P3H1 AHNAK SVIL MKI67 PYCR1 SENP2 ANKRD52 KNL1 PCNT | 3.15e-06 | 1049 | 183 | 19 | 27880917 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NUSAP1 FLNA FLNB ILF3 DSTN GATAD2A MYO5A DHX37 SLU7 U2AF2 RPL14 DDB1 GFPT1 GSN TASOR2 EEF2 AHNAK SVIL MKI67 C3 WDR1 | 3.27e-06 | 1257 | 183 | 21 | 36526897 |
| Pubmed | 3.32e-06 | 225 | 183 | 9 | 12168954 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | NUSAP1 SEH1L ASXL1 ILF3 DTL AGGF1 ERGIC2 DDB1 TASOR2 TUBGCP6 ORC2 PHKB MICALL2 P3H1 AHNAK SVIL POC1B MKI67 ANAPC5 KNL1 | 3.35e-06 | 1155 | 183 | 20 | 20360068 |
| Pubmed | SEH1L FLNA SIGMAR1 ATG2B SPTLC1 DDB1 DCAF5 GFPT1 ADSL RAB3GAP2 ALDH9A1 VARS1 | 3.93e-06 | 437 | 183 | 12 | 20562859 | |
| Pubmed | 4.50e-06 | 298 | 183 | 10 | 30737378 | ||
| Pubmed | 4.56e-06 | 234 | 183 | 9 | 36243803 | ||
| Pubmed | ILF3 ATR EP400 SIN3A MED13L TFAP4 HIRA TIMM21 SFXN3 RPRD2 MED12 KNL1 | 5.66e-06 | 453 | 183 | 12 | 29656893 | |
| Pubmed | PIKES Analysis Reveals Response to Degraders and Key Regulatory Mechanisms of the CRL4 Network. | 6.04e-06 | 49 | 183 | 5 | 31973889 | |
| Pubmed | FLNA FLNB ILF3 DSTN MYO5A RPL14 STAT3 GSN EEF2 AHNAK MKI67 PYCR1 WDR1 GNB3 TAP1 VARS1 | 6.05e-06 | 803 | 183 | 16 | 36517590 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | FLNA FLNB ILF3 DSTN MYO5A U2AF2 RPL14 GSN HIRA EEF2 UBAP2L AHNAK SVIL MKI67 | 6.51e-06 | 626 | 183 | 14 | 33644029 |
| Pubmed | 6.62e-06 | 245 | 183 | 9 | 21182205 | ||
| Pubmed | 7.78e-06 | 250 | 183 | 9 | 33536335 | ||
| Pubmed | 8.12e-06 | 52 | 183 | 5 | 26499835 | ||
| Pubmed | 8.61e-06 | 25 | 183 | 4 | 29475039 | ||
| Pubmed | 8.93e-06 | 53 | 183 | 5 | 34026424 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 8.99e-06 | 91 | 183 | 6 | 28558017 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | NUSAP1 SEH1L FLNA FLNB RPL14 XPNPEP1 BIRC6 DDB1 GFPT1 STAT3 OSBP EEF2 TRNT1 ADSL P3H1 AHNAK RAB3GAP2 CTH WDR1 ALDH9A1 KIF13A VARS1 | 9.16e-06 | 1455 | 183 | 22 | 22863883 |
| Pubmed | Analysis of HIV-1 Gag protein interactions via biotin ligase tagging. | 9.80e-06 | 54 | 183 | 5 | 25631074 | |
| Pubmed | TNIK FLNA RPL14 SLC1A4 GFPT1 GSN RFTN1 EEF2 RASAL3 ALCAM LY75 PLXNA1 NCKAP1L | 1.04e-05 | 565 | 183 | 13 | 20458337 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | FLNA FLNB ANK3 ZFYVE16 RPL14 FAM171B EEF2 MAVS EPHA2 AHNAK SVIL SPRED1 DHX29 | 1.04e-05 | 565 | 183 | 13 | 25468996 |
| Pubmed | SEH1L FLNA FLNB ILF3 MYO5A U2AF2 DDB1 GSN P3H1 EPHA2 AHNAK SVIL MKI67 WDR1 | 1.18e-05 | 660 | 183 | 14 | 32780723 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MYO5A SIGMAR1 CCDC28A DHX37 SRP54 SLU7 DDB1 STAT3 GSN P4HA1 UBAP2L MTIF2 ALDH9A1 RBM41 PCNT | 1.22e-05 | 754 | 183 | 15 | 33060197 |
| Pubmed | NUSAP1 FLNB BIRC6 PHKB MKI67 PIP4K2B DHX29 ANKRD52 PLXNA1 ZNF292 | 1.25e-05 | 335 | 183 | 10 | 15741177 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NUSAP1 GATAD2A MYO5A DHX37 AGGF1 SLU7 RPL14 SIN3A BIRC6 DDB1 UBAP2L SCAPER MKI67 DHX29 MED12 | 1.31e-05 | 759 | 183 | 15 | 35915203 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ASXL1 GATAD2A EP400 HIPK1 AGGF1 SLU7 SIN3A TFAP4 STAT3 HIRA ORC2 P4HA1 A2ML1 CTH ANKRD52 VARS1 | 1.35e-05 | 857 | 183 | 16 | 25609649 |
| Pubmed | 1.42e-05 | 340 | 183 | 10 | 29478914 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | EP400 AAMDC HIPK1 DTL FAM111B PIK3C2B PIP4K2A ARID5B ANKRD52 GARRE1 LRIF1 KNL1 PCNT | 1.58e-05 | 588 | 183 | 13 | 38580884 |
| Pubmed | FLNA FLNB DSTN ANK3 ZFYVE16 HIPK1 U2AF2 DDB1 LRP5 SPRED1 CHD6 KIF13A KNL1 | 1.67e-05 | 591 | 183 | 13 | 15231748 | |
| Pubmed | 1.67e-05 | 10 | 183 | 3 | 25578879 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLNA FLNB ILF3 DSTN GATAD2A AAMDC U2AF2 RPL14 SIN3A BIRC6 DDB1 GFPT1 STAT3 GSN EEF2 ADSL UBAP2L AHNAK PYCR1 CTH VARS1 | 1.95e-05 | 1415 | 183 | 21 | 28515276 |
| Pubmed | 1.98e-05 | 215 | 183 | 8 | 35973513 | ||
| Pubmed | Developmental basis for filamin-A-associated myxomatous mitral valve disease. | 2.29e-05 | 11 | 183 | 3 | 22843703 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TNIK ILF3 DHX37 SPTLC1 SRP54 U2AF2 SIN3A BIRC6 GFPT1 TIMM21 RAB3GAP2 WDR1 ALDH9A1 DHX29 | 2.40e-05 | 704 | 183 | 14 | 29955894 |
| Pubmed | Characterization of the zinc-induced Shank3 interactome of mouse synaptosome. | 2.53e-05 | 109 | 183 | 6 | 29111324 | |
| Pubmed | A conserved acetylation switch enables pharmacological control of tubby-like protein stability. | 2.57e-05 | 223 | 183 | 8 | 33187986 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | FLNA ILF3 GATAD2A EP400 SRP54 SLU7 STAT3 HIRA MAVS UBAP2L AHNAK | 2.59e-05 | 444 | 183 | 11 | 34795231 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNA FLNB ILF3 DSTN ANK3 U2AF2 RPL14 XPNPEP1 DDB1 GFPT1 GSN EEF2 AHNAK WDR1 DISP1 | 2.67e-05 | 807 | 183 | 15 | 30575818 |
| Pubmed | FLNA FLNB ILF3 U2AF2 RPL14 PARP14 DDB1 GFPT1 EEF2 ADSL UBAP2L PIP4K2A C3 VARS1 | 2.67e-05 | 711 | 183 | 14 | 33022573 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 17635842 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 18779368 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 15838885 | ||
| Pubmed | Filamin depletion blocks endoplasmic spreading and destabilizes force-bearing adhesions. | 2.75e-05 | 2 | 183 | 2 | 21325628 | |
| Pubmed | STAT3-induced WDR1 overexpression promotes breast cancer cell migration. | 2.75e-05 | 2 | 183 | 2 | 27521604 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 11336782 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 32484605 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 33649519 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 10984423 | ||
| Interaction | FNDC5 interactions | SEH1L FLNA FLNB SIGMAR1 SPTLC1 GPX7 RPL14 SIN3A ERGIC2 ZFYVE1 DDB1 DCAF5 GFPT1 ECHDC3 EEF2 FAT1 ADSL MAVS P4HA1 UBAP2L P3H1 MTIF2 ASXL3 AHNAK RAB3GAP2 PIP4K2A A2ML1 SFXN3 PYCR1 PIP4K2B C3 TAP1 VARS1 PLXNA1 | 2.53e-07 | 1470 | 180 | 34 | int:FNDC5 |
| Interaction | CFD interactions | SEH1L FLNA FLNB SIGMAR1 SPTLC1 GPX7 RPL14 SIN3A ERGIC2 ZFYVE1 DDB1 DCAF5 GFPT1 ECHDC3 EEF2 FAT1 ADSL MAVS P4HA1 UBAP2L P3H1 MTIF2 ASXL3 AHNAK RAB3GAP2 PIP4K2A SFXN3 PYCR1 PIP4K2B TAP1 VARS1 PLXNA1 | 4.16e-07 | 1360 | 180 | 32 | int:CFD |
| Interaction | RICTOR interactions | FLNA FLNB ASXL1 MYO5A ATG2B SRP54 U2AF2 DDB1 GFPT1 GSN MET EEF2 EPHA2 AHNAK RAB3GAP2 SVIL SFXN3 WDR1 DHX29 VARS1 NCKAP1L | 4.48e-06 | 759 | 180 | 21 | int:RICTOR |
| Interaction | POU5F1 interactions | FLNA FLNB ILF3 GATAD2A ATR EP400 MUC16 SIN3A DDB1 HIRA ORC2 EEF2 P4HA1 UBAP2L P3H1 AHNAK DHX29 DNMT3L | 5.25e-06 | 584 | 180 | 18 | int:POU5F1 |
| Interaction | RCOR1 interactions | TNIK FLNA GATAD2A ZFYVE16 ATG2B SIN3A BIRC6 AHNAK RAB3GAP2 ARID5B MKI67 CHD6 ANKRD52 VARS1 MED12 KNL1 | 9.73e-06 | 494 | 180 | 16 | int:RCOR1 |
| Interaction | ISG15 interactions | FLNA FLNB ILF3 DSTN MYO5A U2AF2 SIN3A DDB1 GSN EEF2 UBAP2L AHNAK ARID5B WDR1 TAP1 | 3.92e-05 | 494 | 180 | 15 | int:ISG15 |
| Interaction | SIRT7 interactions | COL5A1 FLNA FLNB ATR MYO5A DHX37 U2AF2 RPL14 BIRC6 DDB1 DCAF5 GFPT1 TASOR2 UBAP2L AHNAK MKI67 ANKRD52 MED12 PCNT | 3.95e-05 | 744 | 180 | 19 | int:SIRT7 |
| Interaction | C2CD4B interactions | 4.40e-05 | 44 | 180 | 5 | int:C2CD4B | |
| Interaction | NUP43 interactions | SEH1L FLNA GATAD2A EP400 SZT2 AVPR2 CCDC168 DDB1 TASOR2 MAVS RAB3GAP2 MKI67 SENP2 CHD6 MED12 KNL1 ZNF292 | 4.74e-05 | 625 | 180 | 17 | int:NUP43 |
| Interaction | FBXO38 interactions | 4.88e-05 | 145 | 180 | 8 | int:FBXO38 | |
| Interaction | H2BC21 interactions | ILF3 GATAD2A EP400 ERVK13-1 SLU7 DDB1 HIRA ORC2 P3H1 AHNAK SVIL MKI67 RPRD2 KIF18B ANAPC5 LRIF1 DNMT3L ZNF292 | 5.41e-05 | 696 | 180 | 18 | int:H2BC21 |
| Interaction | MED4 interactions | FLNB ZFYVE16 ATG2B MED13L FAM111B ADSL UBAP2L AHNAK PIP4K2A PIP4K2B C3 RPRD2 MED12 PCNT | 5.51e-05 | 450 | 180 | 14 | int:MED4 |
| Interaction | PHF21A interactions | FLNA FLNB ZFYVE16 ATG2B BIRC6 DDB1 AHNAK ARID5B CHD6 ANKRD52 KNL1 PCNT | 6.29e-05 | 343 | 180 | 12 | int:PHF21A |
| Interaction | NAA40 interactions | TNIK FLNA ILF3 EP400 ZFYVE16 ATG2B SRP54 RPL14 SIN3A DDB1 GFPT1 STAT3 ORC2 MAVS UBAP2L AHNAK MKI67 RPRD2 WDR1 DHX29 KNL1 PCNT | 6.38e-05 | 978 | 180 | 22 | int:NAA40 |
| Interaction | EED interactions | FLNA FLNB ASXL1 ILF3 DSTN GATAD2A EP400 SZT2 U2AF2 RPL14 SIN3A XPNPEP1 BIRC6 DDB1 GFPT1 STAT3 GSN TASOR2 EEF2 PXDN P4HA1 RAB3GAP2 SVIL WDR1 KIF18B VARS1 DNMT3L PCNT | 8.44e-05 | 1445 | 180 | 28 | int:EED |
| Interaction | PML interactions | FLNA ILF3 GATAD2A ATR EP400 HIPK1 SRP54 SLU7 RPL14 SIN3A PARP14 STAT3 HIRA EEF2 MAVS UBAP2L AHNAK SFXN3 SENP2 TAP1 KNL1 | 9.38e-05 | 933 | 180 | 21 | int:PML |
| Interaction | LRRC31 interactions | 9.76e-05 | 205 | 180 | 9 | int:LRRC31 | |
| Interaction | BAP1 interactions | FLNA FLNB ASXL1 ILF3 DSTN GATAD2A ANK3 MYO5A U2AF2 RPL14 DDB1 TFAP4 GSN PHKB EEF2 FAT1 P4HA1 UBAP2L ASXL3 AHNAK RAB3GAP2 SVIL PYCR1 WDR1 ALDH9A1 VARS1 | 1.11e-04 | 1314 | 180 | 26 | int:BAP1 |
| GeneFamily | WD repeat domain containing | 2.41e-04 | 262 | 113 | 8 | 362 | |
| GeneFamily | Gelsolin/villins | 1.06e-03 | 8 | 113 | 2 | 950 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.35e-03 | 9 | 113 | 2 | 1234 | |
| Coexpression | MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN | TNIK COL5A1 VGLL3 FAM171B RFTN1 VCAN SVIL SPRED1 TRBC2 TRBC1 PCDH18 PLXNA1 | 1.01e-07 | 235 | 182 | 12 | M2256 |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | 6.76e-06 | 187 | 182 | 9 | M6807 | |
| Coexpression | HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP | 7.90e-06 | 68 | 182 | 6 | M41108 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 2.49e-05 | 276 | 182 | 10 | M3063 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | COL5A1 FLNB AAMDC ZFYVE1 GSN THBS3 IGFBP5 ARID5B PCDH18 DISP1 RBM41 | 2.56e-05 | 337 | 182 | 11 | M13206 |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 3.34e-05 | 176 | 182 | 8 | M2981 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | FLNA ATR EP400 MYO5A HIPK1 NDST2 AGGF1 RPL14 SIN3A SLC7A6 PARP14 BIRC6 DCAF5 STAT3 RFTN1 RASAL3 ST3GAL5 AHNAK RAB3GAP2 PIP4K2A GZMK WDR1 TAP1 ZNF292 NCKAP1L | 4.03e-05 | 1492 | 182 | 25 | M40023 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | FLNA AAMDC PARP14 STAT3 GSN ITIH5 RFTN1 PXDN CPQ ST3GAL5 EPHA2 SVIL ARID5B SPRED1 WDR1 ALDH9A1 PCDH18 | 4.24e-05 | 795 | 182 | 17 | M39050 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | ASXL1 POLE2 MED13L ORC2 FAT1 ADSL MTIF2 ARID5B MKI67 PIP4K2B | 5.03e-05 | 300 | 182 | 10 | M8702 |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN | 5.13e-05 | 187 | 182 | 8 | M34027 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 5.64e-05 | 59 | 182 | 5 | M47993 | |
| Coexpression | LOPEZ_MESOTHELIOMA_SURVIVAL_DN | 6.92e-05 | 12 | 182 | 3 | M10263 | |
| Coexpression | GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN | 7.67e-05 | 198 | 182 | 8 | M3248 | |
| Coexpression | GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP | 7.67e-05 | 198 | 182 | 8 | M5018 | |
| Coexpression | GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_DN | 7.94e-05 | 199 | 182 | 8 | M7976 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH2_DN | 7.94e-05 | 199 | 182 | 8 | M5567 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_UP | 8.22e-05 | 200 | 182 | 8 | M5990 | |
| Coexpression | HALLMARK_GLYCOLYSIS | 8.22e-05 | 200 | 182 | 8 | M5937 | |
| Coexpression | GSE39864_WT_VS_GATA3_KO_TREG_DN | 8.22e-05 | 200 | 182 | 8 | M9063 | |
| Coexpression | GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP | 8.22e-05 | 200 | 182 | 8 | M9083 | |
| Coexpression | GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN | 8.22e-05 | 200 | 182 | 8 | M6789 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | COL5A1 FLNA FLNB PXDN IGFBP5 P3H1 AHNAK VCAN SVIL ALCAM PCDH18 | 8.48e-05 | 385 | 182 | 11 | M39264 |
| Coexpression | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP | FLNA FLNB SPIB AAMDC STAT3 GSN MET MICALL2 SFXN3 C3 CTH ALCAM | 9.79e-05 | 461 | 182 | 12 | M14127 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | FLNB ASXL1 ATR ZFYVE16 MED13L HIRA ORC2 RFTN1 FAT1 ST3GAL5 MTIF2 PIP4K2A ARID5B ALCAM GARRE1 ZNF292 PCNT | 1.05e-04 | 856 | 182 | 17 | M4500 |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | TNIK COL5A1 SPTLC1 PARP14 DCAF5 ITIH5 HIRA MSRA RFTN1 CPQ P4HA1 PIP4K2A POC1B ARID5B SPRED1 CTH WDR1 TAP1 PLXNA1 | 1.11e-04 | 1033 | 182 | 19 | M4196 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | FLNA VRK2 ILF3 DSTN SIGMAR1 POLE2 SPTLC1 SRP54 U2AF2 XPNPEP1 DDB1 STAT3 HIRA ORC2 PHKB P4HA1 MTIF2 CTH WDR1 ALDH9A1 ANAPC5 VARS1 MED12 | 1.12e-04 | 1399 | 182 | 23 | M535 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 1.13e-04 | 268 | 182 | 9 | M45796 | |
| Coexpression | LEE_EARLY_T_LYMPHOCYTE_UP | 1.28e-04 | 111 | 182 | 6 | M7357 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL | NUSAP1 SEH1L ASXL1 VRK2 SPIB SIGMAR1 POLE2 DTL GPX7 AGGF1 ERGIC2 SLC1A4 TFAP4 FAM111B ORC2 TRNT1 TIMM21 SCAPER MKI67 ALCAM KIF18B KNL1 PCNT | 1.44e-04 | 1423 | 182 | 23 | M45722 |
| Coexpression | DELPUECH_FOXO3_TARGETS_DN | 1.69e-04 | 40 | 182 | 4 | M2314 | |
| Coexpression | GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN | 1.73e-04 | 167 | 182 | 7 | M361 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | NUSAP1 SEH1L ATR DTL AGGF1 GFPT1 PXDN ADSL P4HA1 P3H1 MTIF2 MKI67 LRIF1 KNL1 | 1.73e-04 | 644 | 182 | 14 | M10501 |
| Coexpression | DESCARTES_ORGANOGENESIS_PRIMITIVE_ERYTHROID_LINEAGE | NUSAP1 ANO2 HIPK1 RPL14 MED13L SLC1A4 MICALL2 ST3GAL5 MKI67 KIF18B ALDH9A1 KNL1 | 1.97e-04 | 497 | 182 | 12 | MM3640 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | TNIK DPP6 ANO2 LRP1B STAT3 ITIH5 FAT1 IGFBP5 CPQ P4HA1 AHNAK ALCAM ALDH9A1 | 2.00e-04 | 574 | 182 | 13 | M39056 |
| Coexpression | ELVIDGE_HYPOXIA_UP | 2.00e-04 | 171 | 182 | 7 | M7363 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP | 2.03e-04 | 228 | 182 | 8 | M2151 | |
| Coexpression | HADDAD_B_LYMPHOCYTE_PROGENITOR | 2.05e-04 | 290 | 182 | 9 | M939 | |
| Coexpression | RODWELL_AGING_KIDNEY_UP | COL5A1 PARP14 RFTN1 PXDN MICALL2 VCAN GZMK TRBC2 TRBC1 LY75 TAP1 VARS1 | 2.12e-04 | 501 | 182 | 12 | M5389 |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | NUSAP1 ASXL1 ATR POLE2 DTL FAT1 IGFBP5 MAVS SPRED1 ALDH9A1 KNL1 | 2.31e-04 | 432 | 182 | 11 | MM419 |
| Coexpression | GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN | 2.46e-04 | 177 | 182 | 7 | M6703 | |
| Coexpression | SOGA_COLORECTAL_CANCER_MYC_UP | 2.71e-04 | 82 | 182 | 5 | M45007 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | ILF3 EP400 GPX7 AGGF1 RPL14 XPNPEP1 SLC7A6 SLC1A4 TFAP4 HIRA RFTN1 ALX1 ADSL UBAP2L RAB3GAP2 MKI67 GNB3 LY75 TAP1 GARRE1 NXPH2 NCKAP1L | 2.82e-04 | 1394 | 182 | 22 | M9585 |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 2.86e-04 | 240 | 182 | 8 | MM976 | |
| Coexpression | ZHU_CMV_24_HR_DN | 3.03e-04 | 84 | 182 | 5 | M4065 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | COL5A1 FLNA GPX7 RFTN1 EEF2 FAT1 PXDN IGFBP5 AHNAK VCAN SVIL ARID5B SPRED1 WDR1 | 3.06e-04 | 681 | 182 | 14 | M39175 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | NUSAP1 ATR MYO5A AGGF1 SRP54 SLU7 ERGIC2 DCAF5 ORC2 PIP4K2A SPRED1 RBM41 | 3.12e-04 | 523 | 182 | 12 | M12707 |
| Coexpression | HORIUCHI_WTAP_TARGETS_UP | 3.26e-04 | 309 | 182 | 9 | M1973 | |
| Coexpression | SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_DN | 3.55e-04 | 188 | 182 | 7 | M40862 | |
| Coexpression | JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP | 3.58e-04 | 382 | 182 | 10 | M38972 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | COL5A1 GATAD2A MYO5A AAMDC POLE2 SPTLC1 GPX7 PGPEP1 MSRA RFTN1 PXDN ADSL TIMM21 CPQ P4HA1 P3H1 AHNAK PYCR1 DISP1 | 3.69e-04 | 1136 | 182 | 19 | M2247 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | COL5A1 FLNB ILF3 SIGMAR1 SPTLC1 SLC7A6 SLC1A4 SIRT3 THBS3 P4HA1 P3H1 | 3.72e-04 | 457 | 182 | 11 | M1613 |
| Coexpression | RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN | 3.76e-04 | 250 | 182 | 8 | M13333 | |
| Coexpression | HORIUCHI_WTAP_TARGETS_DN | 4.21e-04 | 320 | 182 | 9 | M10279 | |
| Coexpression | GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_UP | 4.29e-04 | 194 | 182 | 7 | M6159 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | FLNB ATR MED13L HIRA ORC2 RFTN1 FAT1 ADSL PIP4K2A ARID5B ZNF292 | 4.38e-04 | 466 | 182 | 11 | M13522 |
| Coexpression | GSE22033_WT_VS_PPARG_KO_MEF_UP | 4.42e-04 | 195 | 182 | 7 | M7694 | |
| Coexpression | DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN | 4.50e-04 | 323 | 182 | 9 | M12570 | |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_DN | GLS2 PGPEP1 MSRA IGFBP5 MICALL2 EPHA2 AHNAK VCAN LRP5 PIP4K2B C3 CTH | 4.59e-04 | 546 | 182 | 12 | M3837 |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 4.70e-04 | 197 | 182 | 7 | M7458 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | COL5A1 FLNB ILF3 SIGMAR1 SPTLC1 SLC7A6 SLC1A4 SIRT3 THBS3 P4HA1 P3H1 | 4.71e-04 | 470 | 182 | 11 | MM1053 |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_UP | 4.85e-04 | 198 | 182 | 7 | M9934 | |
| Coexpression | GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP | 4.99e-04 | 199 | 182 | 7 | M8354 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_DN | 4.99e-04 | 199 | 182 | 7 | M9913 | |
| Coexpression | GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP | 4.99e-04 | 199 | 182 | 7 | M7325 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN | 4.99e-04 | 199 | 182 | 7 | M6060 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_DC_UP | 4.99e-04 | 199 | 182 | 7 | M5143 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_UP | 4.99e-04 | 199 | 182 | 7 | M4481 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_UP | 5.14e-04 | 200 | 182 | 7 | M4630 | |
| Coexpression | GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN | 5.14e-04 | 200 | 182 | 7 | M3508 | |
| Coexpression | GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_UP | 5.14e-04 | 200 | 182 | 7 | M9598 | |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_UP | 5.14e-04 | 200 | 182 | 7 | M9584 | |
| Coexpression | GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_UP | 5.14e-04 | 200 | 182 | 7 | M9883 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_UP | 5.14e-04 | 200 | 182 | 7 | M3865 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_UP | 5.14e-04 | 200 | 182 | 7 | M3897 | |
| Coexpression | GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN | 5.14e-04 | 200 | 182 | 7 | M5073 | |
| Coexpression | GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN | 5.14e-04 | 200 | 182 | 7 | M5286 | |
| Coexpression | GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP | 5.14e-04 | 200 | 182 | 7 | M9080 | |
| Coexpression | GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP | 5.14e-04 | 200 | 182 | 7 | M5617 | |
| Coexpression | CHEOK_RESPONSE_TO_HD_MTX_UP | 5.26e-04 | 23 | 182 | 3 | M114 | |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP | 5.40e-04 | 145 | 182 | 6 | M3045 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 5.40e-04 | 145 | 182 | 6 | M1810 | |
| Coexpression | ROVERSI_GLIOMA_COPY_NUMBER_DN | 5.42e-04 | 54 | 182 | 4 | M18630 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-09 | 184 | 182 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-09 | 184 | 182 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-09 | 184 | 182 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-09 | 194 | 182 | 10 | 14b614f039bc866a1348a2728a68b7d254c7748c | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-09 | 194 | 182 | 10 | 68c7bfead1158641928cc276f599b4a79e06c73c | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-09 | 194 | 182 | 10 | f6aeae6a1e4017e341323fd4784c9e3bae00552b | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-07 | 194 | 182 | 9 | 775600880bb77781de48085d8744c1030223de1f | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-07 | 194 | 182 | 9 | 04ecb609d233a4b12e275c604810937830363e17 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-07 | 194 | 182 | 9 | 7b6ec45adb7ece3c8a7b78c5782413b5825effe2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-07 | 196 | 182 | 9 | a2db88fad9bbc55685f8e681d120ef38715ca3c4 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-07 | 197 | 182 | 9 | 7c275a2ac24a9a4f83fceda93a067e754837102f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-07 | 197 | 182 | 9 | 6668f0da54f3bf96769275e668cd57e00b8a5ef9 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.32e-07 | 198 | 182 | 9 | 80b105a7c7d00ea3b5e586831fbb755bd84f9d1a | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.32e-07 | 198 | 182 | 9 | c73e906d2d12d6eba0e606958be16e63a2292cd0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.44e-07 | 200 | 182 | 9 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 2.81e-07 | 157 | 182 | 8 | d4da4057917dda066da0f2aac2621fdaf1fb943b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.15e-07 | 170 | 182 | 8 | 21bfe070e63722672176052b386167ea4c3dc4e5 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.15e-07 | 170 | 182 | 8 | 4ce81608111b9ee7cb974dad2c182f38db3dcd79 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-07 | 171 | 182 | 8 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-07 | 171 | 182 | 8 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-07 | 172 | 182 | 8 | ef33b5e0515c6d29fb6d9a673011c1b68ef264f3 | |
| ToppCell | RSV-Healthy-2|RSV / Virus stimulation, Condition and Cluster | 6.41e-07 | 175 | 182 | 8 | 0e97189585b7afaf3bd622c3ef10c86412393829 | |
| ToppCell | RSV-Healthy-2|Healthy / Virus stimulation, Condition and Cluster | 6.41e-07 | 175 | 182 | 8 | c47440c0b0513e67fe13b85f10dd8a8d42d0e9a3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-07 | 179 | 182 | 8 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.62e-07 | 182 | 182 | 8 | b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.36e-07 | 184 | 182 | 8 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.36e-07 | 184 | 182 | 8 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.36e-07 | 184 | 182 | 8 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.36e-07 | 184 | 182 | 8 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 9.36e-07 | 184 | 182 | 8 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-06 | 190 | 182 | 8 | b69940d16685249167d4c2cf6ad8237ccf6f7590 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-06 | 191 | 182 | 8 | 4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 192 | 182 | 8 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-06 | 192 | 182 | 8 | 97c312c82ec025c13052f8d424b11c0034c8ea54 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 1.29e-06 | 192 | 182 | 8 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 1.34e-06 | 193 | 182 | 8 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.34e-06 | 193 | 182 | 8 | 33349830e9eba506470ad3661fad5e5a283d20ca | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-06 | 193 | 182 | 8 | b835d28de9daeec5213172c96f62b332cda53bb5 | |
| ToppCell | facs-BAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 194 | 182 | 8 | da45811ba07d746e7cba7ed78882b5d98ac7397d | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_progenitor_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 194 | 182 | 8 | 3d25d6ebec8d1b6001f602257cd15b3ba04cf0c1 | |
| ToppCell | BLOOD--(1)_T_cell-(1)_Activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.39e-06 | 194 | 182 | 8 | 6a0cbb9d5c5c4effb02dff654c6c3b184026875c | |
| ToppCell | facs-BAT-Fat-3m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 194 | 182 | 8 | 76b8512fd92014b3ecc42b0a20d6d1df074cba2c | |
| ToppCell | facs-BAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 194 | 182 | 8 | ef0fa9daecd3bf43c6cf56345928cacdbee19779 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-06 | 195 | 182 | 8 | 67670d16ddd5d5ab7bc2254df329f5a7b2581556 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 195 | 182 | 8 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.45e-06 | 195 | 182 | 8 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-06 | 195 | 182 | 8 | 23dc2f8a3a038195a31feee7e3a51094a7a7c23e | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.45e-06 | 195 | 182 | 8 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.45e-06 | 195 | 182 | 8 | cab90c67a7b3119c0d0d2d5e84511c41dcb8765f | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 195 | 182 | 8 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-Trachea-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-06 | 195 | 182 | 8 | 0d1876f6fdc1eafeb60d6fd7da5bce737d2b4a5a | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 195 | 182 | 8 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | control-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.50e-06 | 196 | 182 | 8 | 886f7c865b086d6ebb4a1746865c30af6bbed345 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.50e-06 | 196 | 182 | 8 | c9fb81a0578db6d278b8582d7b3add6c407e6dcf | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.50e-06 | 196 | 182 | 8 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | COPD-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 1.50e-06 | 196 | 182 | 8 | 4930eeb303d174c28fd91021723e26fdf1af9170 | |
| ToppCell | T_cells-GZMK+GZMB+_T_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.50e-06 | 196 | 182 | 8 | b237287def04def371191b054a41ec0b3150da75 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.56e-06 | 197 | 182 | 8 | ff34be81ee77efe60618641fa7c1084442b991d7 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-06 | 197 | 182 | 8 | 9af431323da6d099459b7360af40e5df998cffbd | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.56e-06 | 197 | 182 | 8 | 4e0c3ea4f4a04a41532806edf3bccf7845c86fa5 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4/8-lo|blood / Manually curated celltypes from each tissue | 1.56e-06 | 197 | 182 | 8 | acd678586aa0e4375bc8fbcdaa1a796c8dd23885 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-06 | 198 | 182 | 8 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-06 | 198 | 182 | 8 | a883e25cb7a78b2ecfb15cef4633bdd02dfafb12 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-06 | 198 | 182 | 8 | 55ea8c9d2154ded74c7b851735b24c95bae01de4 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-06 | 198 | 182 | 8 | fc7d8b8e710eedd6cfc1e5393f0c23feac283807 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-06 | 198 | 182 | 8 | d484ac79d6cd29f1d9c192d126c2099f737d5320 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-06 | 198 | 182 | 8 | ac0be1666456cfa8d68588b187d65008e6d5c0e2 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-06 | 198 | 182 | 8 | ddec07c7bc26d35f155537d907b46e2cb5b55b5f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.68e-06 | 199 | 182 | 8 | 75f221c99adaa29f45dbe365f638b8b123eea148 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.68e-06 | 199 | 182 | 8 | ef767641b669eb2ef3461e51548f4dd09292de90 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.68e-06 | 199 | 182 | 8 | d39b40d84c72bdde756b805063317ecfad3784f8 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.68e-06 | 199 | 182 | 8 | 8766796041965a1ba40ad7abdbc244bf1418c209 | |
| ToppCell | Biopsy_Other_PF-Immune-Proliferating_T_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.68e-06 | 199 | 182 | 8 | 1d55d06e658939b78ea046553757821381eaa026 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.68e-06 | 199 | 182 | 8 | 9ef12fad0ba43680a44cb37a319c3060382f5375 | |
| ToppCell | Severe-Lymphoid-T-Proliferating_T|Severe / Condition, Lineage, Cell class and cell subclass | 1.75e-06 | 200 | 182 | 8 | 266270c756fb69945449ce02da04743cd31f8158 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.75e-06 | 200 | 182 | 8 | b6a016132526e910f95bb40038bbb23f301ca023 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | fa1eaf008b54bdf7bbcdec8134460c5f64490de9 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | f99e214eb680fd82a33f2b1524fbfca265d1cc42 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | d85074b362b11e5a523a5325d203a61aa2759a7a | |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_T_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.75e-06 | 200 | 182 | 8 | dd374e153106fff8a22483ba7f63b3fa3d3ab2ea | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-06 | 200 | 182 | 8 | 6145bdee0d9954da7b096be4fe797066a6df2bd0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.75e-06 | 200 | 182 | 8 | 2cc98abf11f5b58707de45a2282f03d47f00f035 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-06 | 200 | 182 | 8 | a637281d91e95734ee4f8510b3780e0272b16fda | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.75e-06 | 200 | 182 | 8 | fcd16d36f67abf154428242b398b71473f281758 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.75e-06 | 200 | 182 | 8 | 146f11b521b4b0c2a69f1ee86fb71011c7658914 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.75e-06 | 200 | 182 | 8 | 6c2543ff19a81c898f9e07d1fea97d16fa96e2bc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.75e-06 | 200 | 182 | 8 | 0f7431f670f3a175377cefae3479403a881bb8fb | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-06 | 200 | 182 | 8 | f95769e24763900eac317c6f8adbf064bae9feaf | |
| ToppCell | Control-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.61e-06 | 148 | 182 | 7 | 662c057030effc9eb61216e81d3967e6983c244f | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.25e-06 | 153 | 182 | 7 | 0ad401cb70b9edfc6ae6ccba6879c6c2b6c4d296 | |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 4.37e-06 | 160 | 182 | 7 | ab769516f9f7798d1390ef215caf22a2d3d53e63 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.75e-06 | 162 | 182 | 7 | af9999e5fcd28ff1f401d52fd220315752c40027 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.75e-06 | 162 | 182 | 7 | 3b89c3758835b7b9f9d4fb0bc8ed06da382fe48b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.75e-06 | 162 | 182 | 7 | f0a92c92c3a6cf9fa11fb279a584e7f328cb7d43 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.15e-06 | 164 | 182 | 7 | 0662cd9d21608efacc336e0a582859f3b9a4951d | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.15e-06 | 164 | 182 | 7 | 5621c2e3fae84d5a2e4f1595e454bcb3a2b3f93c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-06 | 165 | 182 | 7 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 5.80e-06 | 167 | 182 | 7 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.80e-06 | 167 | 182 | 7 | 3b717d33aaf1ef0869cc4bca8432ba8008875cc5 | |
| Computational | Actin cytoskeleton binding. | 7.38e-07 | 30 | 118 | 6 | MODULE_524 | |
| Computational | Genes in the cancer module 419. | 1.61e-06 | 34 | 118 | 6 | MODULE_419 | |
| Computational | Genes in the cancer module 202. | 1.18e-05 | 28 | 118 | 5 | MODULE_202 | |
| Drug | pyrachlostrobin | COL5A1 FLNA FLNB VGLL3 UGT1A5 PARP14 GSN ITIH5 FAT1 IGFBP5 MAVS CPQ EPHA2 AHNAK SVIL MKI67 LRP5 C3 KIF18B TAP1 NXPH2 KNL1 | 5.96e-07 | 811 | 182 | 22 | ctd:C513428 |
| Drug | resveratrol; Down 200; 50uM; MCF7; HG-U133A | NUSAP1 GLS2 GATAD2A ANK3 POLE2 TFAP4 UBAP2L PIP4K2A SFXN3 MKI67 | 2.90e-06 | 188 | 182 | 10 | 595_DN |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.35e-06 | 191 | 182 | 10 | 4168_DN | |
| Drug | Tamoxifen citrate [54965-24-1]; Down 200; 7uM; PC3; HT_HG-U133A | ZFYVE16 AAMDC MED13L SIRT3 HIRA OSBP PIP4K2B WDR1 ANAPC5 RBM41 | 4.03e-06 | 195 | 182 | 10 | 2050_DN |
| Drug | Betazole hydrochloride; Down 200; 27uM; HL60; HT_HG-U133A | SEH1L ILF3 SIGMAR1 PGPEP1 SLC7A6 TFAP4 PIK3C2B PIP4K2B C3 PLXNA1 | 4.21e-06 | 196 | 182 | 10 | 1854_DN |
| Drug | Eburnamonine (-) [4880-88-0]; Up 200; 13.6uM; HL60; HG-U133A | GATAD2A ATR EP400 MED13L SLC1A4 TFAP4 HIRA VCAN PIP4K2A GNB3 | 5.04e-06 | 200 | 182 | 10 | 1788_UP |
| Drug | dicyclohexyl phthalate | DPP6 MGAM DSTN ATR SIGMAR1 SLC1A4 TFAP4 STAT3 GSN RFTN1 OSBP GRHL1 PXDN IGFBP5 ST3GAL5 SPRED1 C3 GRIN3A KISS1 ANAPC5 | 1.29e-05 | 836 | 182 | 20 | ctd:C036042 |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 1.72e-05 | 183 | 182 | 9 | 7088_DN | |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 2.52e-05 | 192 | 182 | 9 | 5930_DN | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; PC3; HT_HG-U133A | 2.97e-05 | 196 | 182 | 9 | 7320_DN | |
| Drug | AH23848 hemicalcium salt hydrate; Down 200; 1uM; MCF7; HT_HG-U133A | 3.09e-05 | 197 | 182 | 9 | 6903_DN | |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; PC3; HT_HG-U133A | 3.09e-05 | 197 | 182 | 9 | 4606_DN | |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 3.09e-05 | 197 | 182 | 9 | 4998_DN | |
| Drug | Sulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 3.21e-05 | 198 | 182 | 9 | 7200_DN | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; HL60; HT_HG-U133A | 3.21e-05 | 198 | 182 | 9 | 2334_DN | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 3.34e-05 | 199 | 182 | 9 | 7233_DN | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.27e-05 | 128 | 177 | 7 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.27e-05 | 128 | 177 | 7 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.27e-05 | 128 | 177 | 7 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.27e-05 | 128 | 177 | 7 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.27e-05 | 128 | 177 | 7 | C0007134 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.26e-05 | 148 | 177 | 7 | C0279702 | |
| Disease | Copper-Overload Cirrhosis | 3.38e-05 | 11 | 177 | 3 | C1876165 | |
| Disease | Liver Cirrhosis, Experimental | COL5A1 FLNA GLS2 MYO5A ZFYVE16 GSN FAT1 PXDN SEMA6D CPQ AHNAK MKI67 PYCR1 SENP2 NCKAP1L | 7.17e-05 | 774 | 177 | 15 | C0023893 |
| Disease | testosterone measurement | DPP6 VRK2 VGLL3 SPEM3 ANK3 MYO5A UGT1A5 SIN3A BIRC6 SEMA6D TIMM21 ST3GAL5 ARID5B LRP5 GREB1 KISS1 USH2A VARS1 MED12 KNL1 | 8.64e-05 | 1275 | 177 | 20 | EFO_0004908 |
| Disease | FG syndrome (is_implicated_in) | 1.07e-04 | 3 | 177 | 2 | DOID:14711 (is_implicated_in) | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 1.07e-04 | 3 | 177 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 1.07e-04 | 3 | 177 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Seckel syndrome 1 | 1.07e-04 | 3 | 177 | 2 | C4551474 | |
| Disease | FG SYNDROME 4 (disorder) | 1.07e-04 | 3 | 177 | 2 | C1845546 | |
| Disease | FG SYNDROME 2 | 1.07e-04 | 3 | 177 | 2 | C1845902 | |
| Disease | FG SYNDROME 3 | 1.07e-04 | 3 | 177 | 2 | C1845567 | |
| Disease | FG syndrome | 1.07e-04 | 3 | 177 | 2 | C0220769 | |
| Disease | FG syndrome | 2.13e-04 | 4 | 177 | 2 | cv:C0220769 | |
| Disease | cognitive inhibition measurement | 2.32e-04 | 50 | 177 | 4 | EFO_0007969 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.91e-04 | 53 | 177 | 4 | C4707243 | |
| Disease | Schizophrenia | A1BG TNIK VRK2 ANK3 SIGMAR1 GSN MSRA MET PIP4K2A GRIN3A GNB3 TAP1 MED12 DNMT3L PCNT | 2.99e-04 | 883 | 177 | 15 | C0036341 |
| Disease | Hepatitis, Chronic | 3.00e-04 | 22 | 177 | 3 | C0019189 | |
| Disease | Chronic active hepatitis | 3.00e-04 | 22 | 177 | 3 | C0520463 | |
| Disease | Chronic Persistent Hepatitis | 3.00e-04 | 22 | 177 | 3 | C0149519 | |
| Disease | Primary microcephaly | 3.00e-04 | 22 | 177 | 3 | C0431350 | |
| Disease | Cryptogenic Chronic Hepatitis | 3.00e-04 | 22 | 177 | 3 | C0524611 | |
| Disease | Malignant Cystosarcoma Phyllodes | 3.54e-04 | 5 | 177 | 2 | C0600066 | |
| Disease | Phyllodes Tumor | 3.54e-04 | 5 | 177 | 2 | C0010701 | |
| Disease | Progeria | 3.54e-04 | 5 | 177 | 2 | C0033300 | |
| Disease | Prostatic Neoplasms | COL5A1 ATR NDST2 LRP1B STAT3 MET RPRD2 CHD6 GREB1 TAP1 MED12 ZNF292 | 3.66e-04 | 616 | 177 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | COL5A1 ATR NDST2 LRP1B STAT3 MET RPRD2 CHD6 GREB1 TAP1 MED12 ZNF292 | 3.66e-04 | 616 | 177 | 12 | C0376358 |
| Disease | Lymphatic Metastasis | 4.98e-04 | 26 | 177 | 3 | C0024232 | |
| Disease | Paratuberculosis | 5.28e-04 | 6 | 177 | 2 | C0030524 | |
| Disease | age at diagnosis, substance-related disorder | 5.28e-04 | 6 | 177 | 2 | EFO_0004918, MONDO_0002494 | |
| Disease | attention deficit hyperactivity disorder, schizophrenia | 6.01e-04 | 64 | 177 | 4 | EFO_0003888, MONDO_0005090 | |
| Disease | 1,5 anhydroglucitol measurement | 6.91e-04 | 29 | 177 | 3 | EFO_0008009 | |
| Disease | neutropenia (implicated_via_orthology) | 7.37e-04 | 7 | 177 | 2 | DOID:1227 (implicated_via_orthology) | |
| Disease | eating disorder | 9.26e-04 | 32 | 177 | 3 | EFO_0005203 | |
| Disease | bitter alcoholic beverage consumption measurement | 1.27e-03 | 133 | 177 | 5 | EFO_0010092 | |
| Disease | hair colour measurement | TNIK ASXL1 ILF3 ZFYVE16 PXDN SEMA6D AHNAK POC1B LRP5 UNC13C PLXNA1 | 1.28e-03 | 615 | 177 | 11 | EFO_0007822 |
| Disease | ovarian neoplasm | 1.31e-03 | 134 | 177 | 5 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 1.45e-03 | 137 | 177 | 5 | C1140680 | |
| Disease | unipolar depression, age at onset | 1.78e-03 | 40 | 177 | 3 | EFO_0003761, EFO_0004847 | |
| Disease | nucleus accumbens volume change measurement | 1.90e-03 | 11 | 177 | 2 | EFO_0021493 | |
| Disease | subiculum volume | 2.20e-03 | 43 | 177 | 3 | EFO_0009399 | |
| Disease | Dental enamel hypoplasia | 2.27e-03 | 12 | 177 | 2 | EFO_1001304 | |
| Disease | Abnormality of the dentition | 2.27e-03 | 12 | 177 | 2 | HP_0000164 | |
| Disease | left ventricular systolic function measurement | 2.35e-03 | 44 | 177 | 3 | EFO_0008206 | |
| Disease | age at menopause | 2.40e-03 | 302 | 177 | 7 | EFO_0004704 | |
| Disease | Malignant neoplasm of salivary gland | 2.50e-03 | 45 | 177 | 3 | C0220636 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression | 2.67e-03 | 13 | 177 | 2 | EFO_0003761, EFO_0003888 | |
| Disease | Salivary Gland Neoplasms | 2.83e-03 | 47 | 177 | 3 | C0036095 | |
| Disease | cortical thickness | TNIK ANO2 FLNB VRK2 GLS2 GATAD2A PGPEP1 TFAP4 ITIH5 MSRA THBS3 ALX1 VCAN ALCAM KIF13A | 3.00e-03 | 1113 | 177 | 15 | EFO_0004840 |
| Disease | schizophrenia, anorexia nervosa | 3.01e-03 | 48 | 177 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | Pneumoconiosis | 3.11e-03 | 14 | 177 | 2 | C0032273 | |
| Disease | Bagassosis | 3.11e-03 | 14 | 177 | 2 | C0004681 | |
| Disease | total brain volume change measurement | 3.11e-03 | 14 | 177 | 2 | EFO_0021504 | |
| Disease | Adenoid Cystic Carcinoma | 3.14e-03 | 100 | 177 | 4 | C0010606 | |
| Disease | antibody measurement | 3.19e-03 | 49 | 177 | 3 | EFO_0004556 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.19e-03 | 49 | 177 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Weight Gain | 3.37e-03 | 102 | 177 | 4 | C0043094 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | VRK2 CDH23 NCAM2 BIRC6 MET SEMA6D UBAP2L RAB3GAP2 POC1B ARID5B ALCAM USH2A | 3.39e-03 | 801 | 177 | 12 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | B-cell acute lymphoblastic leukemia | 3.57e-03 | 15 | 177 | 2 | EFO_0000094 | |
| Disease | Squamous cell carcinoma of the head and neck | 3.78e-03 | 52 | 177 | 3 | C1168401 | |
| Disease | human papilloma virus infection, oropharynx cancer | 3.99e-03 | 53 | 177 | 3 | EFO_0001668, EFO_1001931 | |
| Disease | 2-hydroxyglutarate measurement | 4.06e-03 | 16 | 177 | 2 | EFO_0021506 | |
| Disease | T-Cell Lymphoma | 4.06e-03 | 16 | 177 | 2 | C0079772 | |
| Disease | household income, smoking status measurement, educational attainment, protein intake measurement, carbohydrate intake measurement, alcohol consumption measurement, body mass index, energy intake measurement | 4.06e-03 | 16 | 177 | 2 | EFO_0004340, EFO_0006527, EFO_0007878, EFO_0009374, EFO_0009695, EFO_0010810, EFO_0010811, EFO_0011015 | |
| Disease | aortic measurement | 4.18e-03 | 251 | 177 | 6 | EFO_0020865 | |
| Disease | Benign neoplasm of stomach | 4.59e-03 | 17 | 177 | 2 | C0153943 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 4.59e-03 | 17 | 177 | 2 | C0751883 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 4.59e-03 | 17 | 177 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 4.59e-03 | 17 | 177 | 2 | C0154060 | |
| Disease | Van Buchem disease | 4.59e-03 | 17 | 177 | 2 | C0432272 | |
| Disease | serum metabolite measurement | TNIK GLS2 GATAD2A UGT1A5 SLC7A6 SLC1A4 STAT3 MSRA ADH7 PHKB ARID5B ALCAM WDR1 | 4.75e-03 | 945 | 177 | 13 | EFO_0005653 |
| Disease | Alzheimer disease, age at onset | 4.81e-03 | 343 | 177 | 7 | EFO_0004847, MONDO_0004975 | |
| Disease | attention deficit hyperactivity disorder, Cannabis use | 5.14e-03 | 18 | 177 | 2 | EFO_0003888, EFO_0007585 | |
| Disease | neuroimaging measurement | TNIK ANO2 VRK2 GATAD2A ANK3 SZT2 PGPEP1 TFAP4 ITIH5 VCAN RAB3GAP2 ALCAM WDR1 KIF18B | 5.27e-03 | 1069 | 177 | 14 | EFO_0004346 |
| Disease | Carcinoma, Granular Cell | 5.32e-03 | 116 | 177 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 5.32e-03 | 116 | 177 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 5.32e-03 | 116 | 177 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 5.32e-03 | 116 | 177 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 5.32e-03 | 116 | 177 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 5.32e-03 | 116 | 177 | 4 | C0001418 | |
| Disease | microglial activation measurement | 5.39e-03 | 59 | 177 | 3 | EFO_0010940 | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 5.65e-03 | 60 | 177 | 3 | EFO_0020690 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 5.72e-03 | 19 | 177 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Chronic myeloproliferative disorder | 5.72e-03 | 19 | 177 | 2 | C1292778 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 5.76e-03 | 447 | 177 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | Intellectual Disability | 5.76e-03 | 447 | 177 | 8 | C3714756 | |
| Disease | Post-Traumatic Osteoporosis | 5.92e-03 | 61 | 177 | 3 | C0751406 | |
| Disease | Osteoporosis, Senile | 5.92e-03 | 61 | 177 | 3 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 5.92e-03 | 61 | 177 | 3 | C0001787 | |
| Disease | blood nickel measurement | 5.99e-03 | 120 | 177 | 4 | EFO_0007583 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TGTEHSPGVQPADVK | 41 | Q9H7C9 | |
| LTGATNGHAFETKPE | 286 | Q15699 | |
| VSKFPVIVGHEATGI | 71 | P40394 | |
| DAQKSAQEGVLGPHT | 2116 | Q96L91 | |
| QHPDVAKVSFTGSVP | 221 | P49189 | |
| HSQLTTLGVDGKEFP | 26 | O95445 | |
| PLVTTSAFLGKSQHG | 306 | P51689 | |
| TVPGSHIFEGITKQL | 431 | Q9NX77 | |
| TGSKYPEQVVLVSGH | 276 | Q9Y646 | |
| VLVKFLSGTSPHGTN | 2761 | Q9NR09 | |
| HGKFTIRFQPTTSTG | 876 | P13611 | |
| SGSDPGQLKHVVDVT | 211 | Q9UJW3 | |
| VAGNFHITVGKAIPH | 181 | Q96RQ1 | |
| RFTKGQSPTVVLGAH | 71 | P49863 | |
| LFPIGNSGKEAVHVT | 741 | A8K2U0 | |
| ISLSTTFKQGAPGQH | 41 | P32929 | |
| TQGDGVAKLSINTHP | 401 | P01024 | |
| FGISTPGSDLHVNAK | 5411 | Q09666 | |
| GTGKPSSFEDVHLLQ | 661 | Q8N302 | |
| VIGSHPDESGSKFQL | 151 | P56282 | |
| TGLKTSPVAIFNGHQ | 301 | Q9NZJ0 | |
| HSLAIVSNGETGKEP | 121 | Q9NQ90 | |
| KGFTPLHVAAVSTNG | 271 | Q8NB46 | |
| LVGDVGVTITDPFKH | 56 | P60981 | |
| ETGSGKSTQVPHFLL | 596 | Q7Z478 | |
| GPVGKRHTGTATVFV | 1076 | Q9H251 | |
| GVAPLKATHQAVEGF | 1311 | Q96F81 | |
| NPHTVLKVGAGEGTT | 611 | Q5H9R4 | |
| DPSIKFFHVSSGVDG | 821 | Q96BY7 | |
| PLKVNGAHVESASGF | 176 | Q8IXJ9 | |
| ISSGISQLGHSQPFK | 1861 | Q9C0F0 | |
| DKDAPGTLVGNVVHS | 36 | O95156 | |
| QVHSSLSAGEKPGFL | 756 | Q86YV0 | |
| EGVKSGFVPNTVHSS | 191 | Q14964 | |
| GKGPSLHVANVIDFS | 246 | Q96IZ5 | |
| PLHVSKNGQTVSGLD | 301 | Q14699 | |
| FSSGTENPHGVKAVT | 651 | Q32P28 | |
| IHDGVSKANFSIGPL | 171 | P43630 | |
| KVLSEHGFGPITTDI | 181 | Q9UJ68 | |
| AEITIPKGAESGFHV | 586 | Q9HCL0 | |
| QLKDNVSSPGGATIH | 226 | P32322 | |
| GESSQVLHPGNKVTL | 216 | P04217 | |
| GTEPEVHKTSVVGLF | 121 | Q9UJX4 | |
| GGTLAFVSPSLAVHK | 591 | Q86YP4 | |
| DPVSGSVKTVNVPFH | 526 | Q9H2M9 | |
| EHGKFFIEPKTGVVS | 1296 | Q14517 | |
| GTPSVVTEGFAHSKI | 4706 | Q8WXI7 | |
| AHGLKGTSTSQDPIV | 6656 | Q8WXI7 | |
| PVGGISVKEHFEVNV | 1996 | Q14667 | |
| QRHVIVKSGPGTFLS | 2396 | Q9NZR2 | |
| IHIKSLTGFGPAASI | 1766 | Q71F56 | |
| VFGIDVKEVDPTGHS | 186 | P43363 | |
| KSEGTFGIHVAENPS | 461 | Q7Z434 | |
| SPVKFTHDISVTGNG | 181 | Q8NCT3 | |
| GFSTGHNAPRKVTAV | 481 | Q5T3J3 | |
| SPSSGVTVGKHFVKQ | 986 | Q4ZG55 | |
| SGEKITFLDTPGHAA | 226 | P46199 | |
| IVFLTDGKPTVGETH | 401 | Q86UX2 | |
| TGLQATTKHSGFPVR | 661 | Q86Z02 | |
| GTEEPSNVTVKHNGV | 906 | O43451 | |
| GSFRQKVVEGSLTHP | 226 | O75197 | |
| GKGAQSTPIQHSFLT | 156 | Q8IWP9 | |
| PRKVSGSFAGSVHIT | 621 | Q8IY33 | |
| ISAEGPVFSSGHDLK | 96 | Q96DC8 | |
| SKAGVENGKPTHFTV | 856 | O75369 | |
| TIDVKFNGSHVVGSP | 2356 | O75369 | |
| FNGSHVVGSPFKVRV | 2361 | O75369 | |
| QHKVTVRAGGFEFSP | 1216 | Q9UIW2 | |
| KAVVVTGFGPFGEHT | 6 | Q9NXJ5 | |
| LGSHSVDKSQAAVGP | 91 | Q6ZS72 | |
| GNSGSVEHPFETKKL | 766 | Q96JK2 | |
| TEEFGPHTKAVSGAL | 191 | P55160 | |
| THFGEPLEKVASVGN | 16 | Q15726 | |
| AANDPFTIVHGNTGK | 31 | O60449 | |
| TKSHTVVIGFGPSEL | 791 | Q8NG31 | |
| PTSVQGHVLKAAGEE | 1436 | Q93074 | |
| IETGQQKTVFVGHTG | 171 | P16520 | |
| AFVVKRGVHVSGASP | 376 | Q96RT7 | |
| VDGQRHSVGHTKIPF | 201 | Q9UI32 | |
| TQSKFVGGAENTAHP | 161 | P24593 | |
| AGKVPASVTDVAGHL | 546 | Q6NSJ5 | |
| FQTPGHTEELVAAGK | 1231 | P46013 | |
| LQGHTGPVFTVSFSK | 266 | Q8TC44 | |
| AHVTVSGGTPKGEAV | 306 | Q9BXS6 | |
| KGVVVQGLSFHQPAS | 181 | Q86Y91 | |
| KVTGEVTDPSGKVHF | 626 | P22059 | |
| VTDPSGKVHFALLGT | 631 | P22059 | |
| DISLHGGKTQEVPTA | 2431 | O95613 | |
| PLGLIAHGKTTQSVF | 371 | Q8TCU5 | |
| IQVEHGVTGSFKDRP | 1141 | O00750 | |
| LTSTATKDPEGFVGH | 66 | P13674 | |
| VHPKSGEVQVAASLG | 286 | Q9H158 | |
| NEKQLFHGTDAGSVP | 1676 | Q460N5 | |
| GHSKAPLNETGEVVN | 2571 | Q13535 | |
| SIKTETQPHGFAVGI | 156 | Q9NZI5 | |
| GDKVSETGTFLISPH | 186 | Q8WV48 | |
| LETLPSGEHSGVNKF | 981 | Q9ULE3 | |
| GNPLSGVFKFHVVIT | 561 | Q8TD26 | |
| ADQHVPGSPFSVKVT | 2121 | P21333 | |
| GAGSKVHEFQTLSPE | 516 | P29317 | |
| TVPVQIGSHFLKGVS | 341 | O15063 | |
| PDGTVKTVYANGHQE | 1301 | Q9HC77 | |
| VKHFANQPLIGSETG | 106 | Q9UN19 | |
| SDATAEQGPILTKHG | 511 | Q12906 | |
| GKFEANGSHTEITPE | 4246 | Q12955 | |
| LDFHNLPDGITKTTG | 46 | P20908 | |
| VGQVLGPSSNHLESK | 286 | P20794 | |
| TGVEYHNAGTQTVPK | 261 | Q8NA54 | |
| TFHQTLLKEGTPGSV | 171 | Q6UWL6 | |
| GVASGFKHVVPNEVV | 171 | P06396 | |
| KRGHVFEESQVAGTP | 766 | P13639 | |
| PFGGNLQKTTDSHIA | 1026 | Q8NDH2 | |
| SITKPFDECGGTTHV | 211 | P54198 | |
| KAGSENPSISLHVIG | 346 | P42658 | |
| GSPVFNASGKLVALH | 651 | Q6SJ93 | |
| SKIAVTGTGAHPAFK | 116 | Q96SL4 | |
| VLGVQPTAHEGFKTF | 336 | Q8NFL0 | |
| VAPGQEKISSLSGAH | 136 | Q8IY37 | |
| GVAGAVAVFPKDHSS | 1316 | Q5VT52 | |
| ELTSSGGPTKFEIHI | 256 | Q96EE3 | |
| FVGDGTSNTIESHPK | 316 | Q9BY12 | |
| GPSGQKTIHSEQAVF | 226 | Q13740 | |
| KPTAVNGCVTGHFTS | 11 | Q16531 | |
| LHTTGITLNKPGFEN | 231 | Q6P995 | |
| TVKHGAGAEISTVNP | 376 | P48426 | |
| EGPNFITKEGTVSDH | 751 | Q93100 | |
| AKQVSSVPFLGAAGH | 31 | Q8N9Y4 | |
| IVLSTEKGEAGHSQP | 1731 | Q6ZRI0 | |
| ASGVNSILPKEHGSQ | 1196 | Q9H1H9 | |
| HVVINGFFPGISVKS | 336 | Q13416 | |
| EIHPTKSFISGGSTI | 746 | P08581 | |
| GTGAVKITPAHDQND | 586 | P26640 | |
| HGIPKEQAVGSTQAT | 1081 | Q5T011 | |
| NTAGVVIDGYPVTKH | 1491 | Q5TCS8 | |
| GEEQNHGVKTTQFVP | 256 | Q9HC62 | |
| QGSPVEVTTTNDHGK | 1586 | O75445 | |
| FPVSGHDIRKVGISS | 386 | Q96Q11 | |
| SAFHPDTGEKVVLIG | 76 | Q9BWM7 | |
| TKSPIIFIGTGEHID | 266 | P61011 | |
| GYVQPADTGHTAKLV | 366 | O95425 | |
| ALVFKSVHFPGQAVG | 186 | Q06210 | |
| HINAGPEIGVASTKA | 481 | Q06210 | |
| VIVSGAEGKLHFPES | 316 | Q7RTZ1 | |
| TVKHGAGAEISTVNP | 386 | P78356 | |
| GFTHFQPAQLTTVGK | 156 | P30566 | |
| TKSEVFYPGETVVHG | 141 | Q99720 | |
| TPGVISRVSQLFKGH | 161 | Q96ST3 | |
| PVEGYSEHVGNKTTI | 226 | Q9UNP4 | |
| VSGIPASKLVEAHGT | 236 | Q9NTG7 | |
| AVKSGAHSFISGLPQ | 616 | Q03518 | |
| GSSVGEITGHNKVIN | 136 | O75083 | |
| VEPGAGVFQFSSKHK | 191 | Q01892 | |
| SGLKVVGESLSPAFH | 381 | O15269 | |
| PEIIITGHADGSIKF | 461 | Q9Y2K9 | |
| VLGLAHSTTGPQESK | 921 | Q14865 | |
| SGPSVIQEIHQESGK | 101 | Q5T681 | |
| NFGGISHPKETAVQA | 206 | Q5JXA9 | |
| VHEQPTKGLSGFQEA | 611 | Q9UKE5 | |
| HIAVSAAVFPTGTKG | 451 | Q9NQW7 | |
| FPVAPTSSKQHGVNV | 931 | Q14157 | |
| DITATPGTGDHKVTV | 2051 | Q8NB66 | |
| TAKVSFNKPDSHGGV | 511 | O15394 | |
| SSGVIQESFLHKSPG | 881 | A0A1B0GUW6 | |
| SFGPHAGKLVAIVDV | 16 | P50914 | |
| VNGKEVHSGVSTDPQ | 46 | P01850 | |
| NSSSGNVTHEKIPIG | 201 | P43007 | |
| GGQANHPTAAVVTEK | 126 | P40763 | |
| GSGLSSVTVFKVPHQ | 36 | Q7Z699 | |
| AFPGSQGHTLIKLAT | 241 | Q8TAQ9 | |
| DGVQVTESGKFHISP | 561 | Q92626 | |
| SDHPEIGIKGSFKQT | 216 | O60281 | |
| AESGKVLVVPTDGSH | 26 | P35504 | |
| FLIVGPQKTGTTAIH | 606 | P52849 | |
| GAKFTGTNIAPDEHV | 141 | O95391 | |
| QLKAVTSVSGPGEHL | 831 | P49746 | |
| PDQHLKVVSIFGNTG | 176 | Q9HBF4 | |
| SHPEVIGVFGESVKG | 151 | Q9BVV7 | |
| IFLHPGESVIQVSGK | 86 | O60844 | |
| SGIFVSPKGVLVHTA | 61 | Q92536 | |
| STVVPDSAHKLFIGG | 251 | P26368 | |
| VNGKEVHSGVSTDPQ | 46 | A0A5B9 | |
| LGITEKENVFVGPTH | 1446 | Q5VWN6 | |
| PSVGFDTGLQHQDKS | 306 | A8MV65 | |
| GAKVDYIQGTPVSVH | 1006 | Q8NFY4 | |
| AGVTQFPSHSVIEKG | 21 | A0A5B0 | |
| AGFQSLKTLIPHTDG | 66 | Q01664 | |
| GPLDFSTKGQSINVH | 321 | Q86Y07 | |
| PGEGAHVSAAVAKTV | 256 | P30518 | |
| HPRKVTGASFVVFNG | 1311 | Q7Z3T8 | |
| TPEGSAVHKAISQQG | 21 | Q9UKN1 | |
| EHETIQGVSGVKPTG | 1631 | Q9Y4I1 |